Sally Lynn Hodder is a seasoned physician with extensive experience administering large scientific programs and serving as Principal Investigator for several important NIH-funded U awards. From 2003-2005, I served as Vice President of Virology Medical Affairs, Bristol-Myers Squibb, a position in which I was responsible for administering a $47 MM annual budget and 50-member department that included clinical trials execution and management.

In 2005, she was recruited to New Jersey Medical School, in Newark, NJ to build an HIV program in a community where HIV prevalence was nearly 3% but was (at that time) there was not an active NIH Division of AIDS adult trial site. She successfully competed for both NIH-supported HIV treatment as well as prevention clinical trial sites and the unit was renewed for funding in 2013.

Under her leadership, effective community outreach in Newark, NJ was realized, enabling enrollment and retention of large numbers of trial participants. As Protocol Chair for the HIV Prevention Trials Network 064 trial (a study of HIV incidence and risk behaviors among 2,099 US women), she worked effectively with investigator teams from multiple sites to successfully create and execute this study.

In September 2014, she accepted a position at West Virginia University to direct their Clinical and Translational Science Institute and to serve as PI for their Clinical and Translational Research grant, a U54 cooperative agreement with the National Institute of General Medical Sciences, to develop institutional clinical and translational research infrastructure. Over the past year, this program has provided mentoring to a broad range of investigators and has resulted in more than $5 MM in new external funding.

She is also working as Principal Investigator of West Virginia Clinical and Translational Science Institute. West Virginia

Sally Hodder | Health Sciences Directory | West Virginia University (wvu.edu)